1-6 of 6
Noopur Raje
Close
Sort by
Journal Articles

Proposal for harmonizing the reporting of infections during treatment with bispecific antibodies in multiple myeloma

Heinz Ludwig, Nikhil C. Munshi, Evangelos Terpos, Ilvy Schweitzer, Noopur Raje, Philippe Moreau, Ajay K. Nooka
Journal: Blood Advances
Blood Adv bloodadvances.2024013461.
https://doi.org/10.1182/bloodadvances.2024013461
Published: 2024
Includes: Supplemental data
Journal Articles

It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma

Ruth Choa, Cristina Panaroni, Roma Bhatia, Noopur Raje
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5510–5523.
https://doi.org/10.1182/bloodadvances.2023010822
Published: 2023
Journal Articles

Respiratory infections predominate after day 100 following B-cell maturation antigen–directed CAR T-cell therapy

Jessica S. Little, Megha Tandon, Joseph Seungpyo Hong, Omar Nadeem, Adam S. Sperling, Noopur Raje, Nikhil Munshi, Matthew Frigault, Sara Barmettler, Sarah P. Hammond
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5485–5495.
https://doi.org/10.1182/bloodadvances.2023010524
Published: 2023
Journal Articles

Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma

Clinical Trials & Observations
Matthew J. Frigault, Michael R. Bishop, Jacalyn Rosenblatt, Elizabeth K. O’Donnell, Noopur Raje, Daniella Cook, Andrew J. Yee, Emma Logan, David E. Avigan, Andrzej Jakubowiak, Kit Shaw, Heather Daley, Sarah Nikiforow, Faith Griffin, Christine Cornwell, Angela Shen, Christopher Heery, Marcela V. Maus
Journal: Blood Advances
Blood Adv (2023) 7 (5): 768–777.
https://doi.org/10.1182/bloodadvances.2022007210
Published: 2023
Includes: Supplemental data
Journal Articles

Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study

Clinical Trials & Observations
Evangelos Terpos, Noopur Raje, Peter Croucher, Ramon Garcia-Sanz, Xavier Leleu, Waltraud Pasteiner, Yang Wang, Anthony Glennane, Jude Canon, Charlotte Pawlyn
Journal: Blood Advances
Blood Adv (2021) 5 (3): 725–736.
https://doi.org/10.1182/bloodadvances.2020002378
Published: 2021
Includes: Supplemental data
Journal Articles

Renal response in real-world carfilzomib- vs bortezomib-treated patients with relapsed or refractory multiple myeloma

Clinical Trials & Observations
Shaji Kumar, Alan Fu, Ruben Niesvizky, Sundar Jagannath, Ralph Boccia, Noopur Raje
Journal: Blood Advances
Blood Adv (2021) 5 (2): 367–376.
https://doi.org/10.1182/bloodadvances.2019001059
Published: 2021
Includes: Supplemental data